Damien Lucidarme

2.3k total citations
43 papers, 1.1k citations indexed

About

Damien Lucidarme is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Damien Lucidarme has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 19 papers in Hepatology and 8 papers in Surgery. Recurrent topics in Damien Lucidarme's work include Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (9 papers). Damien Lucidarme is often cited by papers focused on Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (9 papers). Damien Lucidarme collaborates with scholars based in France, Belgium and United Kingdom. Damien Lucidarme's co-authors include B Filoche, G Forzy, Juliette Foucher, Victor de Lédinghen, Antoine Cortot, J Fruit, D. Camus, Jean–Frédéric Colombel, Christine Faille and Daniel Poulain and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Damien Lucidarme

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damien Lucidarme France 16 597 356 309 246 182 43 1.1k
Geri Brown United States 20 475 0.8× 458 1.3× 281 0.9× 112 0.5× 96 0.5× 48 1.3k
G. Bresci Italy 21 616 1.0× 760 2.1× 432 1.4× 100 0.4× 266 1.5× 56 1.4k
T. Poralla Germany 19 382 0.6× 372 1.0× 220 0.7× 92 0.4× 88 0.5× 56 973
Heimo Nurmi Finland 11 485 0.8× 364 1.0× 341 1.1× 99 0.4× 136 0.7× 14 886
Isabelle Rosa France 17 613 1.0× 569 1.6× 156 0.5× 150 0.6× 73 0.4× 49 972
G. S. A. McDonald Ireland 17 881 1.5× 928 2.6× 571 1.8× 132 0.5× 148 0.8× 50 1.7k
Kentaro Kikuchi Japan 24 735 1.2× 753 2.1× 351 1.1× 142 0.6× 110 0.6× 65 1.5k
Cyriel Ponsioen Netherlands 18 593 1.0× 175 0.5× 556 1.8× 217 0.9× 684 3.8× 40 1.3k
Linsheng Guo United States 13 1.0k 1.7× 1.0k 2.9× 254 0.8× 101 0.4× 138 0.8× 15 1.5k
Marielle Cohard France 12 1.1k 1.9× 943 2.6× 297 1.0× 185 0.8× 486 2.7× 22 1.9k

Countries citing papers authored by Damien Lucidarme

Since Specialization
Citations

This map shows the geographic impact of Damien Lucidarme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Lucidarme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Lucidarme more than expected).

Fields of papers citing papers by Damien Lucidarme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Lucidarme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Lucidarme. The network helps show where Damien Lucidarme may publish in the future.

Co-authorship network of co-authors of Damien Lucidarme

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Lucidarme. A scholar is included among the top collaborators of Damien Lucidarme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Lucidarme. Damien Lucidarme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amiot, Xavier, Isabelle Ollivier‐Hourmand, Christophe Renou, et al.. (2019). Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients. European Journal of Gastroenterology & Hepatology. 31(10). 1270–1274. 1 indexed citations
2.
Robaeys, Geert, Stefan Christensen, Damien Lucidarme, et al.. (2017). Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study. Infectious Diseases and Therapy. 6(2). 265–275. 4 indexed citations
3.
4.
Napoléon, Bertrand, Anne‐Isabelle Lemaistre, B. Pujol, et al.. (2014). A novel approach to the diagnosis of pancreatic serous cystadenoma: needle-based confocal laser endomicroscopy. Endoscopy. 47(1). 26–32. 124 indexed citations
5.
Duburque, Clotilde, et al.. (2014). Life-threatening air embolism during ERCP. Endoscopy. 46(S 01). E250–E251. 7 indexed citations
6.
Lucidarme, Damien, et al.. (2013). Endoscopic treatment of iatrogenic gastrointestinal perforations: An overview. Digestive and Liver Disease. 46(3). 195–203. 36 indexed citations
7.
Duburque, Clotilde, et al.. (2012). L’acétate de goséréline pourrait-il induire des hépatites d’allure auto-immune ?. Progrès en Urologie. 22(10). 610–612. 1 indexed citations
8.
Martínez, Stella Maris, Juliette Foucher, Sophie Métivier, et al.. (2012). Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy. PLoS ONE. 7(10). e47715–e47715. 53 indexed citations
9.
Lucidarme, Damien, Clotilde Duburque, P. Bulois, & B Filoche. (2011). Evolution of HCV incidence in drug users in France. Epidemiology and Infection. 139(9). 1287–1295. 3 indexed citations
10.
Mirault, Tristan, Damien Lucidarme, Bruno Turlin, et al.. (2007). Non‐invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload. European Journal Of Haematology. 80(4). 337–340. 28 indexed citations
11.
Lucidarme, Damien, A. Decoster, Didier Fremaux, et al.. (2007). Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user population. Gastroentérologie Clinique et Biologique. 31(5). 480–484. 10 indexed citations
12.
Khalil, Ali, et al.. (2005). Maladie de Crohn au cours du traitement de l’hépatite chronique C par interféron et ribavirine. Gastroentérologie Clinique et Biologique. 29(2). 193–196. 16 indexed citations
13.
Lucidarme, Damien & B Filoche. (2004). Hépatite aiguë C : traitement immédiat, précoce ou différé ?. Gastroentérologie Clinique et Biologique. 28(2). 126–128. 2 indexed citations
14.
Lucidarme, Damien, Amélie Bruandet, D. Ilèf, et al.. (2004). Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiology and Infection. 132(4). 699–708. 64 indexed citations
15.
Lucidarme, Damien, et al.. (2003). 593 Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the north and east of France. Hepatology. 38. 447–447. 1 indexed citations
16.
Lucidarme, Damien. (2002). Hépatite C et usage de drogue: épidémiologie, dépistage, histoire naturelle et traitement.. Gastroentérologie Clinique et Biologique. 26(5684). 112–120.
17.
Lucidarme, Damien, et al.. (1997). Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis. Alimentary Pharmacology & Therapeutics. 11(2). 335–340. 19 indexed citations
18.
Lucidarme, Damien, et al.. (1994). [Recurrent acute pancreatitis secondary to a vegetable foreign body in the Wirsung's duct].. PubMed. 18(12). 1154–6.
19.
Lucidarme, Damien, Jean–Frédéric Colombel, Per Brandtzaeg, et al.. (1993). α-chain disease: Analysis of α-chain protein and secretory component in jejunal fluid. Gastroenterology. 104(1). 278–285. 6 indexed citations
20.
Fenaux, Pierre, Damien Lucidarme, Jean Luc Laı̈, & F Bauters. (1989). Favorable cytogenetic abnormalities in secondary leukemia. Cancer. 63(12). 2505–2508. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geri Brown Breakdown of academic impact, for papers by G. Bresci Breakdown of academic impact, for papers by T. Poralla Breakdown of academic impact, for papers by Heimo Nurmi Breakdown of academic impact, for papers by Isabelle Rosa Breakdown of academic impact, for papers by G. S. A. McDonald Breakdown of academic impact, for papers by Kentaro Kikuchi Breakdown of academic impact, for papers by Cyriel Ponsioen Breakdown of academic impact, for papers by Linsheng Guo Breakdown of academic impact, for papers by Marielle Cohard
Rankless by CCL
2026